Federal Data Hub › HRSA 340B · JSON
INNIS COMMUNITY HEALTH CENTER · 340B ID CH0610680
ParticipatingChildren's Hospital
INNIS COMMUNITY HEALTH CENTER INC is a Children's Hospital enrolled in the federal 340B Drug Pricing Program in INNIS, LA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 19 contract-pharmacy arrangement(s) (8 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ELLIOTT PHARMACY | MARINGOUIN, LA | 2016-04-01 | 2023-07-31 | 64859 |
| ELLIOTT PHARMACY #3 | NEW ROADS, LA | 2007-08-08 | 2019-02-08 | 564 |
| ENCORE PHARMACY #1 | FORT WORTH, TX | 2022-05-04 | — | 134032 |
| LIVONIA THRIF-T-WAY PHARMACY | LIVONIA, LA | 2017-04-01 | 2020-07-06 | 64858 |
| POINTE COUPEE PHARMACY | NEW ROADS, LA | 2017-04-01 | 2022-08-17 | 64862 |
| POINTE COUPEE PHARMACY | NEW ROADS, LA | 2023-07-01 | 2023-07-31 | 64862 |
| RECEPT PHARMACY #1 | FORT WORTH, TX | 2022-01-01 | 2022-05-02 | 68909 |
| SUPER 1 PHARMACY #648 | NEW ROADS, LA | 2020-04-01 | 2022-01-19 | 117508 |
| WAL-MART CENTRAL FILL 10-2670 | SPRING, TX | 2022-01-01 | — | 70688 |
| WAL-MART PHARMACY 10-0401 | PLAQUEMINE, LA | 2024-04-01 | 2025-12-30 | 4232 |
| WAL-MART PHARMACY 10-0543 | OPELOUSAS, LA | 2024-07-01 | 2025-12-30 | 3753 |
| WAL-MART PHARMACY 10-1128 | MANSURA, LA | 2024-04-01 | — | 4629 |
| WAL-MART PHARMACY 10-1136 | PORT ALLEN, LA | 2024-04-01 | — | 4230 |
| WAL-MART PHARMACY 10-1196 | NEW ROADS, LA | 2020-04-01 | — | 4237 |
| WAL-MART PHARMACY 10-5997 | ORLANDO, FL | 2022-01-01 | — | 39270 |
| WALKER'S PHARMACY | LIVONIA, LA | 2020-07-06 | 2023-12-29 | 127422 |
| WALMART PHARMACY 10-5125 | OPELOUSAS, LA | 2024-04-01 | 2024-04-01 | 101796 |
| WALMART PHARMACY 10-5169 | ROGERS, AR | 2023-07-01 | — | 66076 |
| Walmart Pharmacy 10-7611 | Plainfield, IN | 2024-04-01 | — | 140224 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.